Inactive Instrument

Morison PLC Stock

MORI.N0000

LK0091N00005

Morison PLC., formerly J.L. Morison Son & Jones (Ceylon) PLC, is a Sri Lanka-based pharmaceutical manufacturer. In addition to manufacturing pharmaceutical and over-the-counter (OTC) products, the Company is also engaged in importing and distribution of healthcare and consumer products. It is engaged in the trading in manufacturing, importing and distribution of pharmaceuticals, medical aid, hair care products, diagnostics reagent and equipment and other consumer products. The Company's OTC and consumer category includes brands, such as Morison's Lacto Calamine, Morison's Gripe Mixture and Valmelix Cough Syrup.

Employees

Sector

Pharmaceuticals

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
MORI.N0000 Stock

The best tools reserved for subscribers to boost the performance of your investments!

06-17	Morison Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
25-06-04	Morison Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
24-05-31	Morison Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
23-05-22	Morison Limited Reports Earnings Results for the Full Year Ended March 31, 2023	CI
22-05-23	Morison Limited Reports Earnings Results for the Full Year Ended March 31, 2022	CI
20-09-03	Morison PLC Appoints Sanjit Singh Lamba as Independent Non-Executive Director	CI
20-08-08	Morison plc Reports Earnings Results for the First Quarter Ended June 30, 2020	CI
20-07-09	Morison PLC Appoints Sanjit Singh Lamba as Independent Non-Executive Director, Effective September 1, 2020	CI
20-06-24	Morison PLC Announces Retirement of Steven Mark Enderby as Non Independent Non Executive Director, Effective September 30, 2020	CI
20-05-29	Morison plc Reports Earnings Results for the Full Year Ended March 31, 2020	CI
20-02-12	Morison plc Reports Earnings Results for the Third Quarter Ended December 31, 2019	CI
19-10-25	Morison PLC Reports Earnings Results for the Second Quarter Ended September 30, 2019	CI
19-07-23	Morison plc Reports Earnings Results for the First Quarter Ended June 30, 2019	CI

Manager	Title	Age	Since
Athapaththu M. D. K. Athapaththu CEO	Chief Executive Officer	-	-
Moiz Rehmanjee DFI	Director of Finance/CFO	-	-

Director	Title	Age	Since
Ranjan Chakravarti BRD	Director/Board Member	-	2016-09-30
Murtaza Abidhusein Esufally CHM	Chairman	-	2017-10-26
Athapaththu M. D. K. Athapaththu BRD	Director/Board Member	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MORISON PLC	-.--%	-.--%	-	-	24.88M
ELI LILLY AND COMPANY	+2.45%	+8.11%	+90.85%	+132.54%	1,057B
JOHNSON & JOHNSON	+0.74%	+2.04%	+49.36%	+50.79%	625B
ABBVIE INC.	-0.13%	-0.31%	+23.01%	+61.35%	435B
ROCHE HOLDING AG	+1.58%	+4.80%	+51.48%	+39.79%	363B
NOVARTIS AG	+0.65%	+1.85%	+32.06%	+39.99%	296B
ASTRAZENECA PLC	+0.79%	+4.26%	+8.64%	+7.42%	249B
AMGEN INC.	+0.74%	+8.73%	+44.49%	+57.19%	222B
NOVO NORDISK A/S	+0.34%	+1.27%	-5.10%	-50.94%	209B
GILEAD SCIENCES, INC.	+0.19%	+1.55%	+10.55%	+66.48%	165B
Average	+0.66%	+0.94%	+33.93%	+44.96%	402.31B
Weighted average by Cap.	+1.04%	+1.33%	+49.10%	+66.20%

Morison PLC Stock

Stocks

MORI.N0000

LK0091N00005

Pharmaceuticals

Latest news : Morison PLC

Press Releases: Morison PLC

Managers and Directors: Morison PLC

Other Pharmaceuticals

Company Profile